Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $15.11 $17.90 Friday, 10th May 2024 ACAD stock ended at $15.25. This is 0.263% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.78% from a day low at $15.11 to a day high of $15.53.
90 days $15.11 $26.78
52 weeks $15.11 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Nov 28, 2016 $27.92 $28.00 $27.20 $27.33 1 176 452
Nov 25, 2016 $28.31 $28.40 $27.14 $28.04 777 826
Nov 23, 2016 $25.97 $28.28 $25.55 $28.22 1 837 557
Nov 22, 2016 $28.75 $28.83 $26.57 $26.72 2 473 383
Nov 21, 2016 $29.60 $29.81 $28.15 $28.63 2 094 232
Nov 18, 2016 $29.30 $30.00 $29.25 $29.53 1 937 333
Nov 17, 2016 $28.72 $29.39 $28.31 $29.10 1 295 598
Nov 16, 2016 $28.76 $29.97 $27.91 $28.55 2 068 074
Nov 15, 2016 $28.88 $28.88 $27.75 $28.47 1 831 524
Nov 14, 2016 $29.00 $29.27 $27.60 $29.06 2 294 160
Nov 11, 2016 $29.00 $29.93 $28.33 $28.81 2 561 603
Nov 10, 2016 $29.71 $30.23 $28.73 $29.74 3 973 914
Nov 09, 2016 $28.09 $29.20 $27.37 $28.87 5 739 315
Nov 08, 2016 $26.84 $26.84 $26.84 $26.84 8 587 769
Nov 07, 2016 $22.99 $22.99 $22.99 $22.99 2 936 200
Nov 04, 2016 $21.69 $21.69 $21.69 $21.69 1 593 400
Nov 03, 2016 $20.87 $20.87 $20.87 $20.87 2 932 600
Nov 02, 2016 $22.00 $22.00 $22.00 $22.00 2 020 100
Nov 01, 2016 $22.93 $22.93 $22.93 $22.93 2 184 000
Oct 31, 2016 $23.31 $23.31 $23.31 $23.31 2 117 700
Oct 28, 2016 $22.57 $22.57 $22.57 $22.57 2 002 400
Oct 27, 2016 $22.56 $22.56 $22.56 $22.56 2 440 300
Oct 26, 2016 $23.18 $23.18 $23.18 $23.18 1 963 500
Oct 25, 2016 $23.61 $23.61 $23.61 $23.61 1 863 700
Oct 24, 2016 $23.72 $23.72 $23.72 $23.72 4 178 000
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT